Although metreleptin was approved by the Food and Drug Administration in 2014, it has common side effects like headache, ovarian cysts, ear infection, high levels of protein in the urine, fever, and leptin resistance [32,33]. This evidence concerns the gene LEP and Ovarian cyst.